10-Q Filing

KYNTRA BIO, INC. CIK: 921299 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0000950170-23-039070`
Period End Date	20230630
Filing Date	20230807
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	fgen-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 104 Income Statement 68 Cash Flow Statement 92 Stockholders Equity 36 Comprehensive Income 20

Balance Sheet 104 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable from related parties	`AccountsReceivableRelatedPartiesCurrent`	$19.95M	USD	Point-in-time
Accounts receivable from related parties	`AccountsReceivableRelatedPartiesCurrent`	$12.09M	USD	Point-in-time
Accounts payable to related party	`AccountsPayableRelatedPartiesCurrent`	-	USD	Point-in-time
Accounts payable to related party	`AccountsPayableRelatedPartiesCurrent`	$4.58M	USD	Point-in-time
Accrued and other current liabilities to related party	`DueToRelatedPartiesCurrent`	$63.89M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$155.70M	USD	Point-in-time
Accrued and other current liabilities to related party	`DueToRelatedPartiesCurrent`	$25.23M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$152.59M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$266.31M	USD	Point-in-time
Deferred revenue current to related party	`DueToRelatedPartiesDeferredRevenueCurrent`	$9.26M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$183.13M	USD	Point-in-time
Deferred revenue current to related party	`DueToRelatedPartiesDeferredRevenueCurrent`	$3.48M	USD	Point-in-time
Accounts receivable, net ($19,951 and $12,088 from related parties)	`AccountsReceivableNetCurrent`	$16.30M	USD	Point-in-time
Deferred revenue non-current to related party	`DueToRelatedPartiesDeferredRevenueNoncurrent`	$31.04M	USD	Point-in-time
Deferred revenue non-current to related party	`DueToRelatedPartiesDeferredRevenueNoncurrent`	$12.02M	USD	Point-in-time
Accounts receivable, net ($19,951 and $12,088 from related parties)	`AccountsReceivableNetCurrent`	$25.60M	USD	Point-in-time
Inventories	`InventoryNet`	$40.44M	USD	Point-in-time
Other long-term liabilities due to related party	`DueToRelatedPartiesNoncurrent`	$577.00K	USD	Point-in-time
Inventories	`InventoryNet`	$41.18M	USD	Point-in-time
Other long-term liabilities due to related party	`DueToRelatedPartiesNoncurrent`	-	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$14.08M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$8.86M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$411.36M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	125.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$492.83M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	125.00M	shares	Point-in-time
Restricted time deposits	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.07M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Restricted time deposits	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.07M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Long-term investments	`LongTermInvestmentExcludingEquityMethodInvestments`	-	USD	Point-in-time
Long-term investments	`LongTermInvestmentExcludingEquityMethodInvestments`	$4.35M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$16.83M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$20.61M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	225.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	225.00M	shares	Point-in-time
Equity method investment in unconsolidated variable interest entity	`EquityMethodInvestments`	$5.06M	USD	Point-in-time
Equity method investment in unconsolidated variable interest entity	`EquityMethodInvestments`	$6.11M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$79.89M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	94.17M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	98.20M	shares	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$74.40M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	94.17M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	98.20M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.35M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.28M	USD	Point-in-time
Total assets	`Assets`	$515.13M	USD	Point-in-time
Total assets	`Assets`	$610.09M	USD	Point-in-time
Accounts payable ($4,578 and $0 to a related party)	`AccountsPayableCurrent`	$12.80M	USD	Point-in-time
Accounts payable ($4,578 and $0 to a related party)	`AccountsPayableCurrent`	$30.76M	USD	Point-in-time
Accrued and other current liabilities ($25,229 and $63,886 to a related party)	`AccruedLiabilitiesAndOtherLiabilities`	$162.77M	USD	Point-in-time
Accrued and other current liabilities ($25,229 and $63,886 to a related party)	`AccruedLiabilitiesAndOtherLiabilities`	$219.77M	USD	Point-in-time
Deferred revenue ($3,485 and $9,259 to related parties)	`ContractWithCustomerLiabilityCurrent`	$7.49M	USD	Point-in-time
Deferred revenue ($3,485 and $9,259 to related parties)	`ContractWithCustomerLiabilityCurrent`	$12.74M	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$10.29M	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$11.01M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$194.07M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$273.56M	USD	Point-in-time
Product development obligations	`AccruedProductDevelopmentCosts`	$16.92M	USD	Point-in-time
Product development obligations	`AccruedProductDevelopmentCosts`	$17.36M	USD	Point-in-time
Deferred revenue, net of current	`ContractWithCustomerLiabilityNoncurrent`	$165.42M	USD	Point-in-time
Deferred revenue, net of current	`ContractWithCustomerLiabilityNoncurrent`	$185.72M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$73.81M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$79.59M	USD	Point-in-time
Senior secured term loan facilities, non-current	`SecuredLongTermDebt`	-	USD	Point-in-time
Senior secured term loan facilities, non-current	`SecuredLongTermDebt`	$71.41M	USD	Point-in-time
Liability related to sale of future revenues, non-current	`LiabilityRelatedToSaleOfFutureRevenuesNonCurrent`	$48.40M	USD	Point-in-time
Liability related to sale of future revenues, non-current	`LiabilityRelatedToSaleOfFutureRevenuesNonCurrent`	$49.33M	USD	Point-in-time
Other long-term liabilities ($577 and $0 to a related party)	`OtherLiabilitiesNoncurrent`	$6.44M	USD	Point-in-time
Other long-term liabilities ($577 and $0 to a related party)	`OtherLiabilitiesNoncurrent`	$4.96M	USD	Point-in-time
Total liabilities	`Liabilities`	$575.43M	USD	Point-in-time
Total liabilities	`Liabilities`	$611.57M	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable non-controlling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	-	USD	Point-in-time
Redeemable non-controlling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$21.48M	USD	Point-in-time
Preferred stock, $0.01 par value; 125,000 shares authorized; no shares issued and outstanding at June 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; 125,000 shares authorized; no shares issued and outstanding at June 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value; 225,000 shares authorized at June 30, 2023 and December 31, 2022; 98,204 and 94,166 shares issued and outstanding at June 30, 2023 and December 31, 2022	`CommonStockValue`	$942.00K	USD	Point-in-time
Common stock, $0.01 par value; 225,000 shares authorized at June 30, 2023 and December 31, 2022; 98,204 and 94,166 shares issued and outstanding at June 30, 2023 and December 31, 2022	`CommonStockValue`	$982.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.54B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.63B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.72M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-6.25M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.56B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.72B	USD	Point-in-time
Total stockholders' deficit attributable to FibroGen	`StockholdersEquity`	$-102.27M	USD	Point-in-time
Total stockholders' deficit attributable to FibroGen	`StockholdersEquity`	$-21.45M	USD	Point-in-time
Nonredeemable non-controlling interests	`NonredeemableNoncontrollingInterest`	$19.97M	USD	Point-in-time
Nonredeemable non-controlling interests	`NonredeemableNoncontrollingInterest`	$20.49M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-28.89M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-81.79M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$178.01M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.48M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$123.75M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$229.11M	USD	Point-in-time
Total liabilities, redeemable non-controlling interests and deficit	`LiabilitiesAndStockholdersEquity`	$610.09M	USD	Point-in-time
Total liabilities, redeemable non-controlling interests and deficit	`LiabilitiesAndStockholdersEquity`	$515.13M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$80.48M	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$44.32M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$90.63M	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$29.81M	USD	1 Quarter
Cost of goods sold	`CostOfRevenue`	$9.20M	USD	2 Qtrs
Cost of goods sold	`CostOfRevenue`	$5.71M	USD	1 Quarter
Cost of goods sold	`CostOfRevenue`	$11.05M	USD	2 Qtrs
Cost of goods sold	`CostOfRevenue`	$6.81M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$159.98M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$70.96M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$169.96M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$95.48M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$31.18M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$30.26M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$60.82M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$65.45M	USD	2 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$132.37M	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$108.03M	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$244.62M	USD	2 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$231.85M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-88.05M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-141.22M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-164.14M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-78.22M	USD	1 Quarter
Interest expense	`InterestExpense`	$141.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$3.07M	USD	1 Quarter
Interest expense	`InterestExpense`	$238.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$5.44M	USD	2 Qtrs
Interest income and other income (expenses), net	`NonoperatingIncomeExpense`	$5.20M	USD	1 Quarter
Interest income and other income (expenses), net	`NonoperatingIncomeExpense`	$2.65M	USD	1 Quarter
Interest income and other income (expenses), net	`NonoperatingIncomeExpense`	$3.69M	USD	2 Qtrs
Interest income and other income (expenses), net	`NonoperatingIncomeExpense`	$4.88M	USD	2 Qtrs
Total interest and other, net	`InterestIncomeExpenseNonoperatingNet`	$-1.75M	USD	2 Qtrs
Total interest and other, net	`InterestIncomeExpenseNonoperatingNet`	$5.06M	USD	1 Quarter
Total interest and other, net	`InterestIncomeExpenseNonoperatingNet`	$-417.00K	USD	1 Quarter
Total interest and other, net	`InterestIncomeExpenseNonoperatingNet`	$4.64M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-136.58M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-88.47M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-73.17M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-165.89M	USD	2 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-235.00K	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$23.00K	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$136.00K	USD	2 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-161.00K	USD	2 Qtrs
Investment income in unconsolidated variable interest entity	`IncomeLossFromEquityMethodInvestments`	$1.35M	USD	2 Qtrs
Investment income in unconsolidated variable interest entity	`IncomeLossFromEquityMethodInvestments`	$565.00K	USD	1 Quarter
Investment income in unconsolidated variable interest entity	`IncomeLossFromEquityMethodInvestments`	$550.00K	USD	1 Quarter
Investment income in unconsolidated variable interest entity	`IncomeLossFromEquityMethodInvestments`	$885.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-72.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-164.38M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-135.83M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-87.68M	USD	1 Quarter
Net loss per share - basic	`EarningsPerShareBasic`	$-0.78	USD	1 Quarter
Net loss per share - basic	`EarningsPerShareBasic`	$-0.90	USD	1 Quarter
Net loss per share - basic	`EarningsPerShareBasic`	$-1.71	USD	2 Qtrs
Net loss per share - basic	`EarningsPerShareBasic`	$-1.46	USD	2 Qtrs
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.90	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	$-1.71	USD	2 Qtrs
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.78	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	$-1.46	USD	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	93.47M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	96.22M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	97.73M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	93.26M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	93.47M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	93.26M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	97.73M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	96.22M	shares	2 Qtrs

Cash Flow Statement 92 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-135.83M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-164.38M	USD	2 Qtrs
Depreciation	`Depreciation`	$4.97M	USD	2 Qtrs
Depreciation	`Depreciation`	$5.02M	USD	2 Qtrs
Amortization of finance lease right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$657.00K	USD	2 Qtrs
Amortization of finance lease right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$269.00K	USD	2 Qtrs
Net accretion of premium and discount on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.51M	USD	2 Qtrs
Net accretion of premium and discount on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.81M	USD	2 Qtrs
Investment income in unconsolidated variable interest entity	`InvestmentGainLossInUnconsolidatedVariableInterestEntity`	$1.35M	USD	2 Qtrs
Investment income in unconsolidated variable interest entity	`InvestmentGainLossInUnconsolidatedVariableInterestEntity`	$885.00K	USD	2 Qtrs
Loss (gain) on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$1.00K	USD	2 Qtrs
Loss (gain) on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$-1.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$32.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$33.81M	USD	2 Qtrs
Acquired in-process research and development expenses	`ResearchAndDevelopmentInProcess`	$24.64M	USD	2 Qtrs
Acquired in-process research and development expenses	`ResearchAndDevelopmentInProcess`	-	USD	2 Qtrs
Non-cash interest expense related to sale of future revenues	`NonCashInterestExpenseRelatedToSaleOfFutureRevenues`	$3.58M	USD	2 Qtrs
Non-cash interest expense related to sale of future revenues	`NonCashInterestExpenseRelatedToSaleOfFutureRevenues`	-	USD	2 Qtrs
Impairment of investment	`ImpairmentOfInvestments`	-	USD	2 Qtrs
Impairment of investment	`ImpairmentOfInvestments`	$1.00M	USD	2 Qtrs
Realized loss on sales of available-for-sale securities	`DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment`	$-271.00K	USD	2 Qtrs
Realized loss on sales of available-for-sale securities	`DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment`	$-5.00K	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$10.01M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$16.20M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$1.95M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$10.86M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-11.60M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-4.20M	USD	2 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-5.30M	USD	2 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-6.26M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-1.49M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-99.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.19M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-20.78M	USD	2 Qtrs
Accrued and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-57.02M	USD	2 Qtrs
Accrued and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$61.01M	USD	2 Qtrs
Operating lease liabilities, current	`IncreaseDecreaseInOperatingLeaseLiabilitiesCurrent`	$108.00K	USD	2 Qtrs
Operating lease liabilities, current	`IncreaseDecreaseInOperatingLeaseLiabilitiesCurrent`	$787.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$9.65M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-25.55M	USD	2 Qtrs
Accrued interest for finance lease liabilities	`IncreaseDecreaseInAccruedInterestForFinanceLeaseLiabilities`	$14.00K	USD	2 Qtrs
Accrued interest for finance lease liabilities	`IncreaseDecreaseInAccruedInterestForFinanceLeaseLiabilities`	$68.00K	USD	2 Qtrs
Operating lease liabilities, non-current	`IncreaseDecreaseInOperatingLeaseLiabilitiesNonCurrent`	$-5.67M	USD	2 Qtrs
Operating lease liabilities, non-current	`IncreaseDecreaseInOperatingLeaseLiabilitiesNonCurrent`	$-5.57M	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-1.24M	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-7.06M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-212.16M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-41.54M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.58M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.54M	USD	2 Qtrs
Payment made for acquired in-process research and development asset	`PaymentsToAcquireInProcessResearchAndDevelopment`	$35.00M	USD	2 Qtrs
Payment made for acquired in-process research and development asset	`PaymentsToAcquireInProcessResearchAndDevelopment`	-	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$6.00K	USD	2 Qtrs
Purchases of available-for-sale securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$104.54M	USD	2 Qtrs
Purchases of available-for-sale securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$59.12M	USD	2 Qtrs
Cash acquired from consolidation of Fortis	`CashAcquiredFromAcquisition`	-	USD	2 Qtrs
Cash acquired from consolidation of Fortis	`CashAcquiredFromAcquisition`	$656.00K	USD	2 Qtrs
Proceeds from sales of available-for-sale securities	`ProceedsFromSalesOfAvailableForSaleSecurities`	$1.73M	USD	2 Qtrs
Proceeds from sales of available-for-sale securities	`ProceedsFromSalesOfAvailableForSaleSecurities`	$7.38M	USD	2 Qtrs
Proceeds from maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$192.94M	USD	2 Qtrs
Proceeds from maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$132.52M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$43.24M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$89.20M	USD	2 Qtrs
Proceeds from senior secured term loan facilities, net of issuance costs	`ProceedsFromIssuanceOfSecuredDebt`	$74.08M	USD	2 Qtrs
Proceeds from senior secured term loan facilities, net of issuance costs	`ProceedsFromIssuanceOfSecuredDebt`	-	USD	2 Qtrs
Cash paid for transaction costs for senior secured term loan facilities	`RepaymentsOfSecuredDebt`	$2.75M	USD	2 Qtrs
Cash paid for transaction costs for senior secured term loan facilities	`RepaymentsOfSecuredDebt`	-	USD	2 Qtrs
Repayments of finance lease liabilities	`RepaymentsOfFinanceLeaseLiabilities`	$207.00K	USD	2 Qtrs
Repayments of finance lease liabilities	`RepaymentsOfFinanceLeaseLiabilities`	$23.00K	USD	2 Qtrs
Repayments of lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$201.00K	USD	2 Qtrs
Repayments of lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$201.00K	USD	2 Qtrs
Cash paid for payroll taxes on restricted stock unit releases	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	2 Qtrs
Cash paid for payroll taxes on restricted stock unit releases	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$3.36M	USD	2 Qtrs
Proceeds from issuance of common stock under ATM Program, net of commissions	`ProceedsFromIssuanceInitialPublicOffering`	$48.41M	USD	2 Qtrs
Proceeds from issuance of common stock under ATM Program, net of commissions	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	2 Qtrs
Proceeds from issuance of common stock under employee stock plans	`ProceedsFromIssuanceOfCommonStock`	$3.69M	USD	2 Qtrs
Proceeds from issuance of common stock under employee stock plans	`ProceedsFromIssuanceOfCommonStock`	$2.78M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$123.02M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-806.00K	USD	2 Qtrs
Effect of exchange rate change on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-3.17M	USD	2 Qtrs
Effect of exchange rate change on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-4.36M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.12M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.46M	USD	2 Qtrs
Total cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$155.70M	USD	Point-in-time
Total cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$152.59M	USD	Point-in-time
Total cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$171.22M	USD	Point-in-time
Total cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$167.76M	USD	Point-in-time
Total cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$155.70M	USD	Point-in-time
Total cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$152.59M	USD	Point-in-time
Total cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$171.22M	USD	Point-in-time
Total cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$167.76M	USD	Point-in-time

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-28.89M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-81.79M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$178.01M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.48M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$123.75M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$229.11M	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-72.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-164.38M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-135.83M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-87.68M	USD	1 Quarter
Consolidation of Fortis (Note 3)	`StockIssuedDuringPeriodSharesAcquisitions`	520,000.00	shares	2 Qtrs
Consolidation of Fortis (Note 3)	`StockIssuedDuringPeriodSharesAcquisitions`	520,000.00	shares	1 Quarter
Change in unrealized gain or loss on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$657.00K	USD	1 Quarter
Change in unrealized gain or loss on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-584.00K	USD	1 Quarter
Change in unrealized gain or loss on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-3.17M	USD	2 Qtrs
Change in unrealized gain or loss on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$2.06M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$159.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.34M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$408.00K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.58M	USD	2 Qtrs
Issuance of common stock under ATM Program	`StockIssuedDuringPeriodValueNewIssues`	$48.41M	USD	2 Qtrs
Issuance of common stock under ATM Program	`StockIssuedDuringPeriodValueNewIssues`	$17.28M	USD	1 Quarter
Shares issued from stock plans, net of payroll taxes paid	`AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid`	$-580.00K	USD	2 Qtrs
Shares issued from stock plans, net of payroll taxes paid	`AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid`	$2.78M	USD	1 Quarter
Shares issued from stock plans, net of payroll taxes paid	`AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid`	$3.69M	USD	2 Qtrs
Shares issued from stock plans, net of payroll taxes paid	`AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid`	$2.12M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.88M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$33.81M	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$16.66M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$32.00M	USD	2 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-28.89M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-81.79M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$178.01M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.48M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$123.75M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$229.11M	USD	Point-in-time

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-72.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-164.38M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-135.83M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-87.68M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$159.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.34M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$408.00K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.58M	USD	2 Qtrs
Unrealized gain (loss) on investments, net of tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-584.00K	USD	1 Quarter
Unrealized gain (loss) on investments, net of tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.17M	USD	2 Qtrs
Unrealized gain (loss) on investments, net of tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$2.06M	USD	2 Qtrs
Unrealized gain (loss) on investments, net of tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$657.00K	USD	1 Quarter
Other comprehensive gain (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTax`	$-530.00K	USD	2 Qtrs
Other comprehensive gain (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTax`	$-2.77M	USD	2 Qtrs
Other comprehensive gain (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTax`	$-425.00K	USD	1 Quarter
Other comprehensive gain (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTax`	$-1.68M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-164.91M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-89.36M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-138.60M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-73.05M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.